+49 (0) 541 / 40666 200

Sie erreichen uns Montag bis
Freitag von 8 bis 16 Uhr

 

Schreiben Sie uns eine Email oder benutzten eine andere Kontaktmöglichkeit
 Versandkostenfrei in Deutschland
Einkaufskorb
Keine Artikel
in Ihrem
Einkaufskorb

Bad Blood

Secrets and Lies in a Silicon Valley Startup - 250 - 5494205

Taschenbuch von John Carreyrou

87353383
Zum Vergrößern anklicken

12,89 €

(portofrei!, inkl. MwSt.)

Widerruf zu diesem Artikel
  • Details
  • Beschreibung
  • Information zum Autor
  • Bilder
Details
Artikel-Nr.:
87353383
Im Sortiment seit:
26.05.2018
Erscheinungsdatum:
21.05.2018
Medium:
Taschenbuch
Einband:
Kartoniert / Broschiert
Autor:
Carreyrou, John
Verlag:
Random House LCC US
Imprint:
Alfred A. Knopf
Sprache:
Englisch
Rubrik:
Wirtschaft
Einzelne Wirtschaftszweige
Seiten:
352
Gewicht:
561 gr
Beschreibung
NEW YORK TIMES BEST SELLER • NAMED ONE OF THE BEST BOOKS OF THE YEAR BY: NPR, The New York Times Book Review, Time, Wall Street Journal, Washington Post • The McKinsey Business Book of the Year

The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multibillion-dollar biotech startup founded by Elizabeth Holmes-now the subject of the HBO documentary The Inventor-by the prize-winning journalist who first broke the story and pursued it to the end.

"The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion." -Bill Gates

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.

A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Information zum Autor
JOHN CARREYROU is a two-time Pulitzer Prize-winning investigative reporter at The Wall Street Journal. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. Carreyrou lives in Brooklyn with his wife and three children.
Bilder